Claire Grover

Claire Grover

Auto-generated profile, based on publicly available information

Claire Grover

School of Informatics, University of Edinburgh , Edinburgh, EH8 9AB

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021
Verified
Conference Paper
Open access
Rosa FilgueiraRosa Filgueira
Rosa Filgueira
CGClaire Grover
Claire Grover
VKVasilios Karaiskos
Vasilios Karaiskos
BABeatrice Alex
Beatrice Alex
SESarah van Eyndhoven
Sarah van Eyndhoven
MTMelissa Terras
Melissa Terras
This paper presents the new facilities provided in defoe, a parallel toolbox for querying a wealth of digitised newspapers and books at scale. defoe has been extended to work with further Natural Language Processing () tools such as the Edinburgh Geoparser, to store the preprocessed text in several storage facilities and to support different types of queries and analyses. We have also extended the collection of XML schemas supported by defoe, increasing the versatility of the tool for the analysis of digital historical textual data at scale. Finally, we have conducted several studies in which we worked with humanities and social science researchers who posed complex and interested questions to large-scale digital collections. Results shows that defoe allows researchers to conduct their studies and obtain results faster, while all the large-scale text mining complexity is automatically handled by defoe.

23 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
MCMichael Camilleri
Michael Camilleri
DGDorian Gouzou
Dorian Gouzou
SASalim Al-Wasity
Salim Al-Wasity
Muthu Rama Krishnan MookiahMuthu Rama Krishnan Mookiah
Muthu Rama Krishnan Mookiah
MHMaria Del C. Valdés Hernández
Maria Del C. Valdés Hernández
WWWilliam Whiteley
William Whiteley
We present the design and implementation of a data curation framework to generate a large-scale clinical brain imaging dataset suitable for artificial intelligence (AI) enabled image analysis, accessible through the Brain Health Data (BHD) initiative. The raw data accessible through the BHD includes approximately 417K magnetic resonance imaging (MRI) and 846K computerized tomography (CT) head scans, linked electronic health records (EHRs), and associated free-text imaging reports from clinical practice between 2010 and 2018 in Scotland, totally exceeding 185 TB storage of brain imaging and associated data. We present the work curating the dataset and the strengths of the BHD, including clinical relevance thanks to its unprecedented scale, population-wide representativeness of a national free-at-the-point-of-service healthcare, long-term follow-up to neurodegenerative disease, and real-world variability. We discuss challenges and lessons learnt in developing the framework to curate the data initially available, including the time needed to obtain relevant permissions, the need for easily accessible, secure, responsive and affordable computational environments, the variability and inconsistencies of clinical data and records, and the challenge of extracting linked clinical data and images at scale, among others. This resource will be crucial for clinical research, fostering the development of personalized medicine approaches, and fast-tracking the implementation of AI models in clinical workflows. We encourage the use of the BHD data through a streamlined application to the Data Research and Innovation Service (eDRIS) of Public Health Scotland (PHS).

13 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
MIMatthew H Iveson
Matthew H Iveson
MMMome Mukherjee
Mome Mukherjee
EDEmma M Davidson
Emma M Davidson
HZHuayu Zhang
Huayu Zhang
LSLaura Sherlock
Laura Sherlock
WWWilliam N Whiteley
William N Whiteley
Importance Understanding the relevance of covert cerebrovascular disease (CCD) for later health will allow clinicians to more effectively monitor and target interventions. Objective To examine the association between clinically reported CCD, measured using natural language processing (NLP), and subsequent disease risk. Design, Setting and Participants We conducted a retrospective e-cohort study using linked health record data. From all people with clinical brain imaging in Scotland from 2010 to 2018, we selected people with no prior hospitalisation for neurological disease. The data were analysed from March 2024 to June 2025. Exposure Four phenotypes were identified with NLP of imaging reports: white matter hypoattenuation or hyperintensities (WMH), lacunes, cortical infarcts and cerebral atrophy. Main outcomes and measures Hazard ratios (aHR) for stroke, dementia, and Parkinson’s disease (conditions previously associated with CCD), epilepsy (a brain-based control condition) and colorectal cancer (a non-brain control condition), adjusted for age, sex, deprivation, region, scan modality, and pre-scan healthcare, were calculated for each phenotype. Results From 395,273 people with brain imaging and no history of neurological disease, 145,978 (37%) had ≥1 phenotype. For each phenotype, the aHR of any stroke was: WMH 1.4 (95%CI: 1.3–1.4), lacunes 1.6 (1.5–1.6), cortical infarct 1.7 (1.6–1.8), and cerebral atrophy 1.1 (1.0–1.1). The aHR of any dementia was: WMH, 1.3 (1.3–1.3), lacunes, 1.0 (0.9–1.0), cortical infarct 1.1 (1.0–1.1) and cerebral atrophy 1.7 (1.7–1.7). The aHR of Parkinson’s disease was, in people with a report of: WMH 1.1 (1.0–1.2), lacunes 1.1 (0.9–1.2), cortical infarct 0.7 (0.6–0.9) and cerebral atrophy 1.4 (1.3–1.5). The aHRs between CCD phenotypes and epilepsy and colorectal cancer overlapped the null. Conclusions and Relevance NLP identified CCD and atrophy phenotypes from routine clinical image reports, and these had important associations with future stroke, dementia and Parkinson’s disease. Prevention of neurological disease in people with CCD should be a priority for healthcare providers and policymakers. Question Are measures of Covert Cerebrovascular Disease (CCD) associated with the risk of subsequent disease (stroke, dementia, Parkinson’s disease, epilepsy, and colorectal cancer)? Findings This study used a validated NLP algorithm to identify CCD (white matter hypoattenuation/hyperintensities, lacunes, cortical infarcts) and cerebral atrophy from both MRI and computed tomography (CT) imaging reports generated during routine healthcare in >395K people in Scotland. In adjusted models, we demonstrate higher risk of dementia (particularly Alzheimer’s disease) in people with atrophy, and higher risk of stroke in people with cortical infarcts. However, associations with an age-associated control outcome (colorectal cancer) were neutral, supporting a causal relationship. It also highlights differential associations between cerebral atrophy and dementia and cortical infarcts and stroke risk. Meaning CCD or atrophy on brain imaging reports in routine clinical practice is associated with a higher risk of stroke or dementia. Evidence is needed to support treatment strategies to reduce this risk. NLP can identify these important, otherwise uncoded, disease phenotypes, allowing research at scale into imaging-based biomarkers of dementia and stroke.

21 January 2026 in GigaScience
Verified
Journal Article
Open access
MCMichael Camilleri
Michael Camilleri
DGDorian Gouzou
Dorian Gouzou
SASalim Al-Wasity
Salim Al-Wasity
Muthu Rama Krishnan MookiahMuthu Rama Krishnan Mookiah
Muthu Rama Krishnan Mookiah
MHMaria Del C. Valdés Hernández
Maria Del C. Valdés Hernández
WWWilliam Whiteley
William Whiteley
Background: We present the design and implementation of a data curation framework to generate a large-scale clinical brain imaging dataset suitable for artificial intelligence (AI) enabled image analysis. Findings: The dataset is accessible through the Brain Health Data (BHD) initiative, which includes ~417,341 magnetic resonance imaging (MRI) and 846,077 computerized tomography head studies, linked electronic health records, and associated free-text imaging reports from clinical practice between 2010 and 2018 in Scotland, exceeding 185 TB in size. The data curation framework was developed during the SCottish AI in Neuroimaging to Predict Dementia and Neurodegenerative Disease (SCANDAN) study, which used a subset of 41,966 MRI series from the BHD for dementia prediction. We describe the processing of the BHD metadata and our multilabel classification output. We discuss the strengths of the BHD, including clinical relevance thanks to its unprecedented scale, population-wide representativeness of a national free-at-the-point-of-delivery healthcare, long-term follow-up to neurodegenerative disease, and real-world variability. We describe the challenges and lessons learnt in developing a framework to curate data, including the time needed to obtain permissions, the need for easily accessible, secure, responsive and affordable computational environments, the variability of clinical data, and the challenge of extracting linked clinical data and images at scale. Conclusion: This resource will be crucial for clinical research, fostering the development of personalized medicine approaches, and fast-tracking the implementation of AI models in clinical workflows. We encourage the use of the BHD data through a streamlined application to the Public Benefit and Privacy Panel for Health and Care via the electronic Data Research and Innovation Service of Public Health Scotland (eDRIS).